How The Gov't Anti-Drug PR Review Got Derailed

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

When the White House issued a solicitation last month for the public relations portion of its anti-drug media campaign, the information was posted in a way that enabled readers to see material they shouldn’t have, such as the contract’s cost: $6 million a year.

Then, for reasons unrelated to the review, a federal judge’s order to shut down the Internet site where the RFQ was posted forced the Office of National Drug Control Policy to withdraw it.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in